Inhibitors of janus kinases

Details for Australian Patent Application No. 2007258710 (hide)

Owner Merck & Co., Inc.

Inventors Machacek, Michelle; Haidle, Andrew; Tempest, Paul; Young, Jonathan R.

Agent Spruson & Ferguson

Pub. Number AU-A-2007258710

PCT Pub. Number WO2007/145957

Priority 60/812,524 09.06.06 US

Filing date 5 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 31/50 (2006.01) - Pyridazines

C07D 487/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/145957 Priority application(s): WO2007/145957

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007258720-Razor handle

2007258694-Administration of anti-CD3 antibodies in the treatment of autoimmune diseases